Mr. Speaker, Dr. Donald Calne, who received his arts, science and doctor of medicine degrees from Oxford University, is director of the neuro degenerative disorders centre at the University of British Columbia.
He has achieved international stature for his work on Parkinsonism. He introduced bromocriptine as a treatment for Parkinson's disease. He has demonstrated that latent damage occurs in the brain even before the symptoms of Parkinsonism appear. He was recently named Officer of the Order of Canada for his research, writings and contributions to international medicine.